Genentech Biooncology
Genentech Biooncology
    • Home 

    • Research Education 

    • Research VEGF 

    • The role of VEGF across tumor types 

    • VEGF in bladder cancer 

    • MVD and progression 

    • GLOSSARY
    • ON
    • OFF
  • Print
  • share
 
 
' The related resources bookmark allows you to jump directly to other pages on the site that contain information directly related to the topics you're currently exploring.
  • Home Page
  • What's New?
  • Tumor Types
  • Molecular Causes of Cancer
  • Biological Pathways
  • Therapeutic Targets
  • Pipeline Molecules
  • Research Education
    • Research ADCs
    • Research Apoptosis
    • Research B cell
    • Research BRAF
    • Research Cancer Immunotherapy
    • Research HDIs
    • Research HER Pathways
    • Research MET
    • Research VEGF
      • Why is the VEGF ligand essential throughout tumor development?
      • What are the strategies for inhibiting the VEGF pathway?
      • What are the effects of direct VEGF ligand inhibition?
      • Why is continued VEGF inhibition important?
      • Why do tumors progress?
      • The role of VEGF across tumor types
        • VEGF in lung cancer
        • VEGF in colorectal cancer
        • VEGF in renal cell carcinoma
        • VEGF in glioblastoma
        • VEGF in ovarian cancer
        • VEGF in bladder cancer
          • High VEGF expression
          • VEGF and prognosis
          • VEGF and progression
          • VEGF and progression in urothelial carcinoma
          • VEGF and MVD
          • MVD and progression
          • Summary
        • VEGF in gastric cancer
        • VEGF in multiple myeloma
        • VEGF in pancreatic cancer
      • Slide decks and videos
      • Glossary
  • Clinical Trials
  • Resources
  • Contact Us
Register for Updates Unsubscribe Share
Register for Updates Unsubscribe Share

Related Resources for this page:

  • Tumor Types
    • Colorectal Cancer
    • Glioblastoma
    • Lung Cancer
    • Ovarian Cancer
    • Pancreatic Cancer
    • Renal Cell Carcinoma
  • Molecular Causes of Cancer
    • Evading growth suppressors
    • Inducing angiogenesis
    • Activating invasion and metastasis
  • Biological Pathways
    • Angiogenic Signaling
    • Apoptosis
    • B-cell Surface Proteins
    • HER Signaling
    • MAPK Signaling
    • PI3K/Akt/mTOR Signaling
  • Therapeutic Targets
    • Bcl-2
    • HER1
    • HER2
    • HER3
    • HER4
    • VEGF
  • Future Directions
    • Antibody-Drug conjugates
      • HER Signaling
    • Glycoengineered Antibodies
      • HER Signaling
    • Non-Antibody Biologics
      • Apoptosis
    • Targeted Small Molecules
      • Apoptosis
      • MAPK Signaling
      • PI3K/Akt/mTOR Signaling
    • Traditional Monoclonal Antibodies
      • Angiogenic Signaling
      • B-cell Surface Proteins
      • HER Signaling

Video

Full VEGF & angiogenesis

View video now

Links

  • VEGF in NSCLC
  • VEGF in CRC
  • VEGF in RCC
  • VEGF in GBM
  • VEGF in ovarian cancer
  • VEGF in gastric cancer
  • VEGF in multiple myeloma
  • VEGF in pancreatic cancer
Share

Microvessel Density (MVD) and Progression

MVD as a prognosticator

Several studies examining the significance of tumor angiogenesis as a prognosticator have recognized an association between increasing microvessel density (MVD) and deteriorating prognosis.1 Bochner et al obtained tissue from 164 patients with invasive primary transitional cell carcinoma (TCC) of the bladder. The level of MVD in the specimens significantly predicted disease-free and overall survival in patients (P<0.0001 and P=0.0007, respectively). The authors concluded that tumor angiogenesis, determined by MVD, is an independent prognostic indicator for patients with invasive TCC of the bladder.1

Reference:
1.
Bochner BH, Cote RJ, Weidner N, et al. J Natl Cancer Inst. 1995;87:1603-1612. PMID: 7563203
 
  • SITEMAP
  • /
  • PRIVACY POLICY
  • /
  • TERMS & CONDITIONS
  • /
  • CONTACT US
  • /
  • © 2013 Genentech USA, Inc. All rights reserved.
  • /
  • BIO0000907901
Next section: Summary »

© 2011 Genentech USA, Inc. All rights reserved